Senti Biosciences Inc.

NASDAQ: SNTI
Share price (12/20/24): $3.97
Market cap (12/20/24): $18.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Exempt offering of securities

Registration of securities for employees

Prospectus supplement

Prospectus supplement

Updated info for already-effective prospectus

Ownership Filter

Bayer Aktiengesellschaft, Bayer Healthcare LLC, Bayer World Investments B.V., Bayer US Holding LP

News Filter

Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration With Celest Therapeutics

Investor Presentation

Bio Appoints Fran Schulz to Board of Directors

Bio Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202, a Logic Gated, Selective CD33/FLT3-Targeting CAR-NK Cell Therapy for the Treatment of Relapsed/Refractory Hematologic Malignancies Including AML

Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness